Instem Launches New In Silico Toxicology Blog
Value-added blog to provide unique industry and regulatory insight and best practice guidance for computational toxicology scientists and professionals
CONSHOHOCKEN, PA – September 10, 2020 - Instem, a leading provider of IT solutions to the global life sciences market, announced today that it has launched In Silico Insider, a bi-weekly Blog developed specifically for scientists and professionals working in the field of Computational Toxicology.
This valuable new resource is co-authored by Dr. Glenn Myatt, Instem’s Vice President of Informatics and Dr. Candice Johnson, Instem’s Lead Research Scientist, who both joined Instem in November 2019 as part of Instem’s acquisition of Leadscope, Inc., a leading provider of In Silico Safety Assessment Solutions.
Dr. Myatt and Dr. Johnson are leading experts in the field of In Silico Toxicology and have built deep relationships with regulatory authorities and leading organizations in the pharmaceutical, chemical and consumer products industries. They have a wealth of experience in the management of international consortia to develop industry protocols and position papers and have a reputation in the market as true collaborators.
“Glenn and Candice’s scientific and regulatory know-how, combined with a clear passion for their field, make them uniquely positioned to provide the insight, thought leadership and proven best practice guidance that the In Silico Tox community highly values,” comments Julie Jones, Informatics Marketing Manager at Instem.
To read the first blog post and to subscribe for future bi-weekly updates, please visit https://insilicoinsider.blog/
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
Leadscope are renowned leaders in computational toxicology and their clients include pharmaceutical, chemical and consumer products organizations, as well as international regulatory agencies. Leadscope’s innovative solutions allow researchers to combine their own proprietary data with publicly-curated toxicity databases. Clients searching Leadscope’s toxicity databases can access well over 500,000 toxicology studies for more than 200,000 chemicals, enabling fast, accurate, defendable and regulatory accepted predictions.
Gary Mitchell, VP Global Marketing (US HQ)
Julie Jones, Marketing Manager (UK HQ)